Acasti Pharma

Home » Acasti Pharma

Secondary

Acasti Pharma

They are a biopharmaceutical innovator focused on the research, development and commercialization of prescription drugs using omega 3, or OM3, fatty acids derived from krill oil.

Symbol

ACST

Last Closing Price
$1.23

Shares
7,300,000

Effective Date
December 20, 2017

Underwriters
Benchmark Company, Dawson James Securities

To view the prospectus for Acasti Pharma, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253